
Biocept BIOC
Quarterly report 2023-Q2
added 08-14-2023
Biocept Total Inventories 2011-2026 | BIOC
Annual Total Inventories Biocept
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 757 K | 2.65 M | 1.93 M | 768 K | 587 K | 499 K | 549 K | 349 K | 189 K | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.65 M | 189 K | 920 K |
Quarterly Total Inventories Biocept
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 551 K | 704 K | 757 K | 1.9 M | 2.25 M | 3.22 M | 2.65 M | 2.9 M | 3.02 M | 3.26 M | 1.93 M | 1.93 M | 1.93 M | 1.93 M | 768 K | 768 K | 768 K | 768 K | 587 K | 587 K | 587 K | 587 K | 499 K | 499 K | 499 K | 499 K | 549 K | 549 K | 549 K | 549 K | 349 K | 349 K | 349 K | 349 K | 189 K | 189 K | 189 K | 189 K | 92.8 K | 92.8 K | 92.8 K | 92.8 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.26 M | 92.8 K | 978 K |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | ||
|
Burning Rock Biotech Limited
BNR
|
123 M | $ 22.9 | 19.89 % | $ 246 M | ||
|
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | ||
|
BioNano Genomics
BNGO
|
13.3 M | $ 1.6 | -0.62 % | $ 2.03 M | ||
|
Co-Diagnostics
CODX
|
1.66 M | $ 6.05 | 6.14 % | $ 178 M | ||
|
Castle Biosciences
CSTL
|
8.14 M | $ 40.8 | 1.83 % | $ 1.13 B | ||
|
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | ||
|
Danaher Corporation
DHR
|
2.33 B | $ 234.89 | -0.73 % | $ 172 B | ||
|
DarioHealth Corp.
DRIO
|
5.06 M | $ 12.11 | -10.18 % | $ 344 M | ||
|
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | ||
|
DexCom
DXCM
|
560 M | $ 70.15 | 0.37 % | $ 27.1 B | ||
|
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
162 M | $ 101.62 | -0.03 % | $ 18.8 B | ||
|
CareDx, Inc
CDNA
|
19.5 M | $ 18.99 | 0.96 % | $ 1.02 B | ||
|
Guardant Health
GH
|
71.1 M | $ 110.12 | -1.97 % | $ 13.5 B | ||
|
Aspira Women's Health
AWH
|
316 K | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
547 M | $ 151.07 | 2.65 % | $ 24 B | ||
|
Charles River Laboratories International
CRL
|
279 M | $ 216.28 | - | $ 11.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
188 M | $ 178.22 | -1.22 % | $ 19.8 B | ||
|
Laboratory Corporation of America Holdings
LH
|
493 M | $ 253.83 | -2.49 % | $ 21.3 B | ||
|
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
2.3 M | $ 202.64 | 0.58 % | $ 16.7 B | ||
|
IDEXX Laboratories
IDXX
|
382 M | $ 710.27 | 0.49 % | $ 58.6 B | ||
|
Lantheus Holdings
LNTH
|
68 M | $ 69.22 | -0.66 % | $ 4.79 B | ||
|
Agilent Technologies
A
|
830 M | $ 147.47 | -0.1 % | $ 44.8 B | ||
|
Biomerica
BMRA
|
1.49 M | $ 2.78 | 5.41 % | $ 6.39 M | ||
|
Bioventus
BVS
|
91.3 M | $ 7.56 | -1.18 % | $ 474 M | ||
|
QIAGEN N.V.
QGEN
|
279 M | $ 47.23 | 0.32 % | $ 10.5 B | ||
|
Mettler-Toledo International
MTD
|
342 M | $ 1 462.87 | -1.54 % | $ 31 B | ||
|
Myriad Genetics
MYGN
|
27.5 M | $ 6.7 | 2.68 % | $ 607 M | ||
|
ENDRA Life Sciences
NDRA
|
2.62 M | $ 4.51 | -1.96 % | $ 2.42 M | ||
|
NeoGenomics
NEO
|
26.7 M | $ 12.69 | -0.78 % | $ 1.61 B |